Embracing the complexity of genomic data for personalized medicine

Genome Research

Volumn 16, Issue 5, 2006, Pages 559-566

  West, Mike ^a   Ginsburg, Geoffrey S ^a,c   Huang, Andrew T ^c,d   Nevins, Joseph R ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; FEMALE; GENE EXPRESSION; GENETICS; GENOME; GENOMICS; HUMAN; MEDICINE; PATHOLOGY; PROGNOSIS; REVIEW; RISK FACTOR; THEORETICAL MODEL; TREATMENT OUTCOME;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; GENOME, HUMAN; GENOMICS; HUMANS; MEDICINE; MODELS, THEORETICAL; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 33745145845     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.3851306     Document Type: Review

References (26)

1. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511. (Pubitemid 30082188)
2. Bild, A., Yao, G., Chang, J.T., Wang, Q., Potti, A., Chasse, D., Joshi, M.-B., Harpole, D., Lancaster, J.M., Berchuck, A., et al. 2006. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357. (Pubitemid 43128862)
3. Black, E.P., Huang, E., Dressman, H., Ishida, S., West, M., and Nevins, J.R. 2003. Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res. 63: 3716-3723. (Pubitemid 36793057)
4. Calvo, K.R., Liotta, L.A., and Petricoin, E.F. 2005. Clinical proteomics: From biomarker discovery and cell signaling profiles to individualized personal therapy. Biosci. Rep. 25: 107-125.
5. Chang, H.Y., Sneddon, J.B., Alizadeh, A.A., Sood, R., West, R.B., Montgomery, K., Chi, J.T., van de Rign, M., Botstein, D., and Brown, P.O. 2004. Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds. PLoS Biol. 2: 206-214.
6. Chang, H.Y., Nuyten, D.S., Sneddon, J.B., Hastie, T., Tibshirani, R., Sorlie, T., Dai, H., He, Y.D., van't Veer, L.J., Bartelink, H., et al. 2005. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc. Natl. Acad. Sci. 102: 3738-3743.
7. Dawber, T.R. 1980. The Framingham Study. Harvard University Press, Cambridge, MA.
8. Ein-Dor, L., Kela, I., Getz, G., Givol, D., and Domany, E. 2005. Outcome signature genes in breast cancer: Is there a unique set? Bioinformatics 21: 171-178. (Pubitemid 40202018)
9. Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J.P., Coller, H., Loh, M.L., Downing, J.R., Caligiuri, M.A., et al. 1999. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
10. Huang, E., Ishida, S., Pittman, J., Dressman, H., West, M., and Nevins, J.R. 2003. Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat. Genet. 34: 226-230. (Pubitemid 36666937)
11. Monti, S., Savage, K.J., Kutok, J.L., Feuerhake, F., Kurtin, P., Mihm, M., Wu, B., Pasqualucci, L., Neuberg, D.S., Aguiar, R.C., et al. 2005. Molecular profiling of diffuse large B cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 105: 1851-1861. (Pubitemid 40731764)
12. Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstrale, M., Laurila, E., et al. 2003. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34: 267-273. (Pubitemid 36792858)
13. Nevins, J.R., Huang, E.S., Dressman, H., Pittman, J., Huang, A.T., and West, M. 2003. Towards integrated clinic-genomic models for personalized medicine: Combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum. Mol. Genet. 12: R153-R157. (Pubitemid 37259327)
14. Perou, C.M., Sorlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H., Akslen, L.A., et al. 2000. Molecular portraits of human breast tumors. Nature 406: 747-752. (Pubitemid 30671230)
15. Pittman, J., Huang, E., Dressman, H., Horng, C.-F., Cheng, S.-H., Tsou, M.-H., Chen, C.-M., Bild, A., Iversen, E.S., Huang, A.T., et al. 2004. Models for individualized prediction of disease outcomes based on multiple gene expression patterns and clinical data. Proc. Natl. Acad. Sci. 101: 8431-8436.
16. Ramaswamy, S. and Golub, T.R. 2002. DNA microarrays in clinical oncology. J. Clin. Oncol. 20: 1932-1941.
17. Sarwal, M., Chua, M.S., Kambham, N., Hsieh, S.C., Satterwhite, T., Masek, M., and Salvatierra, O. 2003. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med. 349: 125-138. (Pubitemid 36818782)
18. Seo, D.M., Wang, T., Dressman, H., Herderick, E.E., Iversen, E., Dong, C., Vata, K., Milano, C.A., Nevins, J.R., Pittman, J., et al. 2004. Gene expression phenotypes of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24: 1922-1927.
19. Staudt, L.M. 2003. Molecular diagnosis of the hematologic cancers. N. Engl. J. Med. 348: 1777-1785.
20. Stoughton, R.B. and Friend, S.H. 2005. How molecular profiling could revolutionize drug discovery. Nat. Rev. Drug Discov. 4: 345-350.
21. Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J.J., Ladd-Acosta, C., Mesirov, J., Golub, T.R., and Jacks, T. 2005. An oncogenic KRAS2 expression signature identified by cross-species gene expression analysis. Nat. Genet. 37: 48-54. (Pubitemid 40070939)
22. Tate, S.K. and Goldstein, D.B. 2004. Will tomorrow's medicines work for everyone? Nat. Genet. 36: S34-S42.
23. Tudor, M., Akbarian, S., Chen, R.Z., and Jaenisch, R. 2002. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl. Acad. Sci. 99: 15536-15541. (Pubitemid 35403969)
24. van't Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A., Mao, M., Peterse, H.L., van der Kooy, K., Marton, M.J., Witteveen, A.T., et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
25. Wilson, P.W.F., D'Agostino, R.B., Levy, D.B., Belanger, A.M., Silbershatz, H., and Kannel, W.B. 1998. Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847. (Pubitemid 28213628)
26. Yanagisawa, K., Shyr, Y., Xu, B.J., Massion, P.P., Larsen, P.H., White, B.C., Roberts, J.R., Edgerton, M., Gonzalez, A., Nadaf, S., et al. 2003. Proteomic patterns of tumour subsets in non-small-cell lung cancr. Lancet 362: 415-416.